Repligen | RGEN - 净收入

金融业

USD

USD 2.93B

现金及等价物

USD 582.65M

USD 85.97M

USD 1.16B

USD 126.21M

USD 546.59M

USD 19.98M

USD 40.01M

1.78K

EPS每股收益

USD 0.48

股本和储备

USD 2.11B

USD 108.28M

债务利息支出

USD 5.58M

USD 7.31M

USD 546.59M

USD 7.01B

USD 8.33M

USD 174.27M

USD 19.98M

普通股股本

USD 56.4M

109.48

USD 19.11M

USD 194M

销售和管理费用

USD 76.54M

USD 179.26M

贸易债权人

USD 34.66M

应收帐款人

USD 151.55M

	净收入	更改		日
Agilent	USD 305M		129M	2025-12
Align Technology	USD 112.77M		22.99M	2026-03
Bio Techne	USD 38.01M		176K	2025-12
BioMarin Pharmaceutical	USD 105.53M		152.1M	2026-03
Bristol-Myers Squibb	USD 2.68B		1.59B	2026-03
Bruker	USD 26M		88.4M	2025-12
Charles River Laboratories	USD -276.56M		330.98M	2025-12
Danaher	USD 1.03B		168M	2026-03
Dentsply International	USD -146M		281M	2025-12
General Electric Aerospace	USD 1.9B		637M	2026-03
Henry Schein	USD 107M		6M	2026-03
Illumina	USD 134M		200M	2026-03
IQVIA Holdings	USD 274M		240M	2026-03
Mettler Toledo International	USD 285.76M		68.27M	2025-12
Myriad Genetics	USD -7.9M		19.5M	2025-12
OraSure Technologies	USD -19.29M		5.57M	2025-12
Pacific Biosciences Of California	USD -40.37M		2.37M	2025-12
Pfizer	USD 2.69B		4.34B	2026-03
Repligen	USD 8.33M		4.95M	2026-03
Revvity	USD 40.72M		57.65M	2026-03
Standard Biotools	USD 19.28M		53.97M	2025-12
Thermo Fisher Scientific	USD 1.65B		313M	2026-03
Waters	USD -72M		297.21M	2026-03
West Pharmaceutical Services	USD 138.8M		6.7M	2026-03